Skip to content

Medical-device intelligence

Dade Behring , Inc.: FDA clearances and recalls

Research Dade Behring , Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

343 clearance records and 28 recall records in the covered releases, across 1 source company names and 107 product codes. Dated history runs from Oct 10, 1978 to Dec 20, 2010.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

371 matching records
Device / recordCompany in FDA recordSourceSource date
Advanced D-Dimer. Fibrinogen and fibrin split products Catalog numbers OQWM11 and OQEM13.Z-0538-05 · DAPDade Behring , Inc.RecallFeb 15, 2005FDA classification date
DIMENSION RXL MAX WITH STREAMLAB ANALYTICAL WORKCELL AND SAMPLE TRANSFER MODULEK043546 · CDTDade Behring, Inc.510(k)Jan 18, 2005FDA decision date
EMIT II PLUS ECSTASY ASSAYK043028 · DKZDade Behring, Inc.510(k)Jan 7, 2005FDA decision date
StreamLab Analytical Workcell. General Purpose Laboratory Device.Z-0373-05 · JJEDade Behring , Inc.RecallDec 28, 2004FDA classification date
ENZYGNOST F+2 (MONOCLONAL) TEST KITK042687 · MIFDade Behring, Inc.510(k)Dec 10, 2004FDA decision date
DADE BEHRING HEPARIN CALIBRATOR AND CONTROLSK042941 · GIZDade Behring, Inc.510(k)Dec 2, 2004FDA decision date
CONTROL PLASMA N, PROC CONTROL PLASMAK042333 · GGNDade Behring, Inc.510(k)Dec 1, 2004FDA decision date
MODIFICATION TO DIMENSION NT-PROBNP FLEX REAGENT CARTRIDGE METHODK042347 · NBCDade Behring, Inc.510(k)Nov 19, 2004FDA decision date
EMIT CAFFEINE ASSAYK042407 · KLSDade Behring, Inc.510(k)Oct 28, 2004FDA decision date
DispoSystem for BCT System.Model number OVFR03. Multipurpose System for in vitro coagulation studies.Z-0042-05 · JPADade Behring , Inc.RecallOct 23, 2004FDA classification date
CONTROL PLASMA N AND CONTROL PLASMA PK042209 · GGNDade Behring, Inc.510(k)Oct 21, 2004FDA decision date
BC Thrombin Reagent . Thrombin Time TestZ-0007-05 · GJADade Behring , Inc.RecallOct 5, 2004FDA classification date
N LATEX CYSTATINK041878 · NDYDade Behring, Inc.510(k)Aug 16, 2004FDA decision date
ADVANCED D-DIMER ASSAYK041438 · DAPDade Behring, Inc.510(k)Aug 11, 2004FDA decision date
Berichrom Heparin Reagent (OWLD11). The reagent is a component in a test kit.Z-1305-04 · KFFDade Behring , Inc.RecallJul 31, 2004FDA classification date
N APOLIPOPROTEIN STANDARD SERUMK041870 · JIXDade Behring, Inc.510(k)Jul 27, 2004FDA decision date
MICROSCAN SYNERGIES PLUS GRAM-NEGATIVE MIC/COMBO PANELSK041150 · LRGDade Behring, Inc.510(k)Jul 22, 2004FDA decision date
DIMENSION NT-PROBNP FLEX REAGENT CARTRIDGE METHOD, DIMENSION PBNP CALIBRATOR, MODELS RF423, RC423K041417 · NBCDade Behring, Inc.510(k)Jul 20, 2004FDA decision date
Pathromtin SL. Partial Thromboplastin Time Tests. The product is sold in kits containing 10 and 20 vialsZ-0773-04 · GFODade Behring , Inc.RecallJul 20, 2004FDA classification date
URINE AMPHETAMINE/METHAMPHETAMINE SCREEN FLEX REAGENT CARTRIDGEK040133 · DKZDade Behring, Inc.510(k)Apr 8, 2004FDA decision date
MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH CEPHALOTHIN (0.5-32 UG/ML)K031601 · LONDade Behring, Inc.510(k)Apr 2, 2004FDA decision date
MICROSCAN DRIED GRAM-NEGATIVE MIC/COMBO PANELS (GEMIFLOXACIN)K033948 · LRGDade Behring, Inc.510(k)Mar 1, 2004FDA decision date
MICROSCAN DRIED GRAM-NEGATIVE MIC/COMBO PANELS-AMOXICILLIN/CLAVULANATE POTASSIUM (AUGMENTIN)K033940 · LTTDade Behring, Inc.510(k)Feb 25, 2004FDA decision date
DIMENSION LIDOCAINE (LIDO) FLEX REAGENT CARTRIDGE METHOD, DIMENSION DRUG CALIBRATOR II, MODELS DF113. DC49DK033809 · KLRDade Behring, Inc.510(k)Feb 20, 2004FDA decision date
MICROSCAN DRIED GRAM-NEGATIVE MIC/COMBO PANELS WITH ERTAPENEM (0.002-32 MCG/MLK032706 · JWYDade Behring, Inc.510(k)Feb 10, 2004FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗